Nakamura A, Boroojeni SF, Haroon N. Aberrant antigen processing and presentation: key pathogenic factors leading to immune activation in Ankylosing spondylitis. Semin Immunopathol. 2021;43(2):245–53.

Article  CAS  PubMed  Google Scholar 

Nakamura A, Haroon N. Recent updates in the immunopathology of type 3 immunity-mediated Enthesitis. Curr Rheumatol Rep. 2021;23(5):31.

Article  CAS  PubMed  Google Scholar 

Van Praet L, Jacques P, Van Den Bosch F, Elewaut D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat Rev Rheumatol. 2012;8(5):288–95.

Article  PubMed  Google Scholar 

Mauro D, Nakamura A, Haroon N, Ciccia F. The gut-enthesis axis and the pathogenesis of Spondyloarthritis. Semin Immunol. 2021;58:101607.

Article  CAS  PubMed  Google Scholar 

Wang Q, Xu R. Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis. BMC Genomics. 2019;20(1).

Choi S-C, Brown J, Gong M, Ge Y, Zadeh M, Li W, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med. 2020;12(551):eaax2220.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu D, Du J, Pu X, Zheng L, Chen S, Wang N et al. The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis. Front Cell Infect Microbiol. 2022;11.

Luo Y, Tong Y, Wu L, Niu H, Li Y, Su LC, et al. Alteration of gut microbiota in individuals at < scp > high-risk for rheumatoid arthritis Associated with disturbed metabolome and the initiation of arthritis through the triggering of Mucosal Immunity Imbalance. Arthritis Rheumatol. 2023;75(10):1736–48.

Article  CAS  PubMed  Google Scholar 

Seymour BJ, Trent B, Allen BE, Berlinberg AJ, Tangchittsumran J, Jubair WK et al. Microbiota-dependent indole production stimulates the development of collagen-induced arthritis in mice. J Clin Invest. 2024;134(4).

Motta F, Carena MC, Selmi C, Vecellio M. MicroRNAs in ankylosing spondylitis: function, potential and challenges. J Transl Autoimmun. 2020;3:100050.

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Feng F, Huang Q, Zheng S, Huang Z, Deng W, et al. Proteomic analysis of serum-derived extracellular vesicles in ankylosing spondylitis patients. Int Immunopharmacol. 2020;87:106773.

Article  CAS  PubMed  Google Scholar 

Wielińska J, Crossland RE, Łacina P, Świerkot J, Bugaj B, Dickinson AM, et al. Exploring the Extracellular vesicle MicroRNA expression repertoire in patients with rheumatoid arthritis and ankylosing spondylitis treated with TNF inhibitors. Dis Markers. 2021;2021:2924935.

Article  PubMed  PubMed Central  Google Scholar 

Tavasolian F, Lively S, Pastrello C, Tang M, Lim M, Pacheco A, et al. Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis. Ann Rheum Dis. 2023;82(11):1429–43.

Article  CAS  PubMed  Google Scholar 

Mahnke J, Schumacher V, Ahrens S, Käding N, Feldhoff LM, Huber M, et al. Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism. Sci Rep. 2016;6(1):35521.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012;61(12):1693–700.

Article  CAS  PubMed  Google Scholar 

Sieper J, Poddubnyy D, Miossec P. The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol. 2019;15(12):747–57.

Article  CAS  PubMed  Google Scholar 

Venken K, Jarlborg M, Decruy T, Mortier C, Vlieghe C, Gilis E, et al. Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. Ann Rheum Dis. 2023;82(8):1076–90.

Article  CAS  PubMed  Google Scholar 

Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65(10):2645–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, et al. Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis. 2019;78(11):1536–44.

Article  PubMed  Google Scholar 

Britanova OV, Lupyr KR, Staroverov DB, Shagina IA, Aleksandrov AA, Ustyugov YY, et al. Targeted depletion of TRBV9 + T cells as immunotherapy in a patient with ankylosing spondylitis. Nat Med. 2023;29(11):2731–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiocchia G, Boissier MC, Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur J Immunol. 1991;21(12):2899–905.

Article  CAS  PubMed  Google Scholar 

Liu Z, Cort L, Eberwine R, Herrmann T, Leif JH, Greiner DL, et al. Prevention of type 1 diabetes in the rat with an allele-specific anti-T-cell receptor antibody: Vβ13 as a therapeutic target and biomarker. Diabetes. 2012;61(5):1160–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maciocia PM, Wawrzyniecka PA, Philip B, Ricciardelli I, Akarca AU, Onuoha SC, et al. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies. Nat Med. 2017;23(12):1416–23.

Article  CAS  PubMed  Google Scholar 

Paul S, Pearlman AH, Douglass J, Mog BJ, Hsiue EH, Hwang MS, et al. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13:584.

Article  Google Scholar 

May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez de Castro JA, et al. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens. 2002;60(4):299–308.

Article  CAS  PubMed  Google Scholar 

Faham M, Carlton V, Moorhead M, Zheng J, Klinger M, Pepin F, et al. Discovery of T cell receptor β motifs specific to HLA-B27-Positive Ankylosing spondylitis by Deep Repertoire sequence analysis. Arthritis Rheumatol. 2017;69(4):774–84.

Article  CAS  PubMed  Google Scholar 

Yang X, Garner LI, Zvyagin IV, Paley MA, Komech EA, Jude KM, et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature. 2022;612(7941):771–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Macleod T, Bridgewood C, McGonagle D. Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders. Lancet Rheumatol. 2023;5(1):e47–57.

Article  CAS  PubMed  Google Scholar 

Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183(6):2593–603.

Article  CAS  PubMed  Google Scholar 

Pointon JJ, Harvey D, Karaderi T, Appleton LH, Farrar C, Stone MA, et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene. Genes Immun. 2010;11(6):490–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol. 2007;8(6):630–8.

Article  CAS  PubMed  Google Scholar 

Rosenzweig HL, Vance EE, Asare-Konadu K, Koney KV, Lee EJ, Deodhar AA, et al. Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Ann Rheum Dis. 2024;83(2):214–22.

Article  CAS  PubMed